Silence Therapeutics PLC(SLN) - 2019 Q4 - Earnings Call Transcript

Silence Therapeutics plc (OTC:SLNCF) Q4 2019 Earnings Conference Call April 14, 2020 8:00 AM ET Company Participants Iain Ross – Interim Executive Chairman Rob Quinn – Chief Financial Officer Giles Campion – Head-R&D and Chief Medical Officer Conference Call Participants Miles Dixon – Peel Hunt Nathaniel Calloway – Edison Group Jens Lindqvist – Investec Iain Ross Hi, good afternoon, everybody. IÂ'm very pleased to be able to present the 2019 results for Silence Therapeutics. I think this is quite an extraor ...